SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-17-007586
Filing Date
2017-08-14
Accepted
2017-08-14 17:21:32
Documents
55
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mbvx10q_june302017.htm 10-Q 886449
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES ex31-1.htm EX-31.1 12349
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES ex31-2.htm EX-31.2 12539
4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION ex32.htm EX-32 11008
5 AUGUST LETTER AGREEMENT DATED AUGUST 9, 2017 ex10-1.htm EX-10.1 28340
  Complete submission text file 0001654954-17-007586.txt   2969564

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mbvx-20170630.xml EX-101.INS 374376
7 XBRL TAXONOMY EXTENSION SCHEMA mbvx-20170630.xsd EX-101.SCH 27153
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbvx-20170630_cal.xml EX-101.CAL 48379
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbvx-20170630_def.xml EX-101.DEF 82993
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbvx-20170630_lab.xml EX-101.LAB 221581
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbvx-20170630_pre.xml EX-101.PRE 177838
Mailing Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121
Business Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001109196 (see all company filings)

IRS No.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37861 | Film No.: 171031648
SIC: 2834 Pharmaceutical Preparations